Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Clinical and Molecular Hepatology. 2022;28(1):47-49 
Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and management
Clinical Liver Disease. 2012;1(4):125-128
Clinical and Genetic Markers of Nonalcoholic Fatty Liver Disease and Prediction of Liver Disease Mortality: Ready for Population Screening?
Gastroenterology. 2020;158(6):1838-1840
Nonalcoholic Fatty Liver Disease Liver Fat Score and Fat Equation to Predict and Quantitate Hepatic Steatosis: Promising But Not Prime Time!
Gastroenterology. 2009;137(3):772-775
Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
Cells. 2022;11(17):2718
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Nonalcoholic Fatty Liver Disease Fibrosis Than Men: Summary of the Findings of a Systematic Review and Meta‐analysis
Clinical Liver Disease. 2021;18(5):251-254
Management of nonalcoholic fatty liver disease in children
Clinical Liver Disease. 2012;1(4):129-130
The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes
Clinical Liver Disease. 2018;12(2):39-44
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease
Clinics in Liver Disease. 2023;27(2):239-250
Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers
Clinical Liver Disease. 2012;1(4):104-107